United Bank (West Virginia)’s iShares Biotechnology ETF IBB Stock Holding History

United Bank (West Virginia)’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	$440K	Hold	3,954	–	–	0.17%	66
2017 Q2	$409K	Sell	3,954 -75	-2%	-$7.39K	0.17%	72
2017 Q1	$394K	Hold	4,029	–	–	0.17%	72
2016 Q4	$356K	Buy	4,029 +1,563	+63%	+$142K	0.16%	76
2016 Q3	$238K	Sell	2,466 -15	-0.6%	-$1.43K	0.11%	94
2016 Q2	$213K	Hold	2,481	–	–	0.1%	97
2016 Q1	$216K	Hold	2,481	–	–	0.1%	103
2015 Q4	$280K	Sell	2,481 -744	-23%	-$80.8K	0.13%	78
2015 Q3	$326K	Sell	3,225 -600	-16%	-$72K	0.17%	69
2015 Q2	$470K	Buy	3,825 +975	+34%	+$117K	0.21%	55
2015 Q1	$326K	Hold	2,850	–	–	0.14%	83
2014 Q4	$288K	Hold	2,850	–	–	0.11%	89
2014 Q3	$260K	Hold	2,850	–	–	0.1%	92
2014 Q2	$244K	Hold	2,850	–	–	0.09%	95
2014 Q1	$225K	Sell	2,850 -2,325	-45%	-$194K	0.09%	101
2013 Q4	$392K	Sell	5,175 -1,335	-21%	-$94.7K	0.16%	73
2013 Q3	$455K	Hold	6,510	–	–	0.2%	54
2013 Q2	$377K	Buy	+6,510	New	+$376K	0.17%	58

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Churchill Management Los Angeles, California $9.21B AUM 19.91% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

United Bank (West Virginia)'s IBB Position: Q3 2017 in Review

United Bank (West Virginia) held its iShares Biotechnology ETF (IBB) position steady in Q3 2017 at 3,954 shares worth $440K. The position accounts for 0.17% of the portfolio, ranked #66.

United Bank (West Virginia) first reported a position in IBB in Q2 2013 and has held it in 18 quarters since. The position peaked at $470K in Q2 2015. 583 funds tracked by Wall St. Rank hold IBB as of Q3 2017.

United Bank (West Virginia) held 3,954 shares of iShares Biotechnology ETF worth $440K as of Q3 2017.
United Bank (West Virginia) left its iShares Biotechnology ETF share count unchanged in Q3 2017.
iShares Biotechnology ETF made up 0.17% of United Bank (West Virginia)'s portfolio in Q3 2017, its #66 holding.
United Bank (West Virginia) first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 18 quarters since.
United Bank (West Virginia)'s iShares Biotechnology ETF position peaked at $470K in Q2 2015.
583 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2017.

Based on United Bank (West Virginia)'s 13F filing for Q3 2017, filed 26 Oct 2017.